<DOC>
	<DOCNO>NCT02097953</DOCNO>
	<brief_summary>The purpose study understand antibiotic , rifampin , may change blood level another antibiotic , daptomycin , body . In addition , effect polymorphism P-glycoprotein ( protein involve removal daptomycin body ) blood level daptomycin evaluate . The hypothesis rifampin decrease blood level daptomycin effect great certain P-glycoprotein polymorphism .</brief_summary>
	<brief_title>Influence Rifampin Co-Administration Pharmacokinetic Profile Daptomycin</brief_title>
	<detailed_description>This open-label , sequential pharmacokinetic study 12 healthy volunteer . After provide informed consent , participant meet inclusion criterion administer daptomycin 6 mg/kg 2 minute blood urine sample collect 24 hour period infusion . Following , participant give 13 day supply rifampin 600 mg/day take home . After completion rifampin course , second pharmacokinetic sampling perform ( day 15 overall ) . Participants administer dose rifampin 600 mg administer daptomycin 6 mg/kg 2 minute blood urine sample collect second 24 hour period . A blood sample obtain first study visit determination participant 's P-glycoprotein genotype .</detailed_description>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Ability provide inform consent If female child bear potential , reliable method contraception negative pregnancy test enrollment Obesity ( body mass index &gt; 30 ) Creatinine clearance &lt; 80 ml/min Creatine phosphokinase &gt; 2 time upper limit normal enrollment Aspartate aminotransferase , alanine aminotransferase , alkaline phosphatase &gt; 3 time upper limit normal enrollment History liver disease cirrhosis History congestive heart failure Allergy intolerance rifampin daptomycin Need concomitant nonstudy medication study period Inability abstain grapefruit juice herbal supplement ( St. John 's wort ) study period Receipt study drug within 30 day prior enrollment Pregnancy lactation Inability adhere study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Daptomycin</keyword>
	<keyword>Rifampin</keyword>
	<keyword>P-glycoprotein</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>